- Home
- CALC vs SER Comparison
CALC vs SER Comparison
Compare CALC & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- SER
- Stock Information
- Founded
- CALC 2011
- SER 2017
- Country
- CALC United States
- SER United States
- Employees
- CALC N/A
- SER N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- CALC Health Care
- SER Health Care
- Exchange
- CALC Nasdaq
- SER Nasdaq
- Market Cap
- CALC 40.3M
- SER 45.2M
- IPO Year
- CALC N/A
- SER 2018
- Fundamental
- Price
- CALC $3.07
- SER $4.92
- Analyst Decision
- CALC Strong Buy
- SER
- Analyst Count
- CALC 5
- SER 0
- Target Price
- CALC $18.20
- SER N/A
- AVG Volume (30 Days)
- CALC 25.7K
- SER 25.9K
- Earning Date
- CALC 11-13-2024
- SER 11-12-2024
- Dividend Yield
- CALC N/A
- SER N/A
- EPS Growth
- CALC N/A
- SER N/A
- EPS
- CALC N/A
- SER N/A
- Revenue
- CALC N/A
- SER $3,157,500.00
- Revenue This Year
- CALC N/A
- SER N/A
- Revenue Next Year
- CALC N/A
- SER N/A
- P/E Ratio
- CALC N/A
- SER N/A
- Revenue Growth
- CALC N/A
- SER 2454.55
- 52 Week Low
- CALC $2.05
- SER $3.81
- 52 Week High
- CALC $8.38
- SER $23.18
- Technical
- Relative Strength Index (RSI)
- CALC 49.36
- SER 48.18
- Support Level
- CALC $2.73
- SER $4.70
- Resistance Level
- CALC $3.22
- SER $5.40
- Average True Range (ATR)
- CALC 0.30
- SER 0.43
- MACD
- CALC 0.01
- SER 0.00
- Stochastic Oscillator
- CALC 40.00
- SER 33.68
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.